Influenza among the elderly in the Americas: A consensus statement

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 33, Issue 6, 2013, Pages 446-452

  Rüttimann, Ricardo W ^a   Bonvehí, Pablo E ^b   Vilar Compte, Diana ^c   Isturiz, Raúl E ^d   Labarca, Jaime A ^e   Vidal, Edison I ^f  

^a UNIVERSITY OF MIAMI   (United States)

^b CEMIC   (Argentina)

^c INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^d Centro Medico Docente La Trinidad   (Venezuela)

^e PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^f SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

80 and over; Aged; Consensus development conferences as topic; Health of the elderly; Human; Immunization; Influenza; Influenza vaccines; Latin America

Indexed keywords

ADULT; DISEASE CONTROL; DISEASE PREVALENCE; ELDERLY CARE; ELDERLY POPULATION; ESTIMATION METHOD; INFECTIOUS DISEASE; INFLUENZA; INFORMATION MANAGEMENT; SYMPTOM;

FLORIDA [UNITED STATES]; LATIN AMERICA; MIAMI; UNITED STATES;

INFLUENZA VACCINE;

AGED; ARTICLE; CONSENSUS DEVELOPMENT; HUMAN; INFLUENZA; VERY ELDERLY; WESTERN HEMISPHERE;

AGED; AGED, 80 AND OVER; AMERICAS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN;

EID: 84882442899     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. World Health Organization. Influenza. Available from: http://www.who.int/media centre/factsheets/2003/fs211/en/Accessed on 22 August 2012.
2. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004;292(11):1333-40. (Pubitemid 39223224)
3. Kuri-Morales P, Galván F, Cravioto P, Zárraga Rosas LA, Tapia-Conyer R. Mortalidad en México por influenza y neumonia (1990-2005). Salud Publica Mex. 2006;48(5):379-84. (Pubitemid 44624719)
4. Pan American Health Organization, Technical Advisory Group on Vaccine-Preventable Diseases. Vaccination against seasonal and pandemic influenza: vaccinate your family, protect your community. In: final report from the proceeding of the XIX TAG meeting. Buenos Aires, Argentina: PAHO; 2011. Pp 18-20.
5. Clark NM, Lynch JP 3rd. Influenza: epidemiology, clinical features, therapy, and prevention. Semin Respir Crit Care Med. 2011;32(4): 373-92.
6. Macadar D, Bay G, United Nations, Economic Commission for Latin America and Caribe. Latin America and Caribbean: population estimates and projections,1950-2050. Available from: http://www.eclac.cl/publicaciones/xml/7/ 14347/lcg2225.pdf Accessed on 14 June 2013.
7. Arden NH. Control of influenza in the long-term-care facility: a review of established approaches and newer options. Infect Control Hosp Epidemiol. 2000 Jan;21(1):59-64.
8. Weinberger B, Grubeck-Loebenstein B. Vaccines for the elderly. Clin Microbiol Infect. 2012;18(5):100-8.
9. Castle SC, Uyemura K, Fulop T, Makinodan T. Host resistance and immune responses in advanced age. Clin Geriatr Med. 2007;23(3): 463-79. (Pubitemid 47044905)
10. Seidman JC, Richard SA, Viboud C, Miller MA. Quantitative review of antibody response to inactivated seasonal influenza vaccines. Influenza Other Respi Viruses. 2012;6(1):52-62.
11. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet. 2012;12(1):36-44.
12. Skowronski DM, Tweed SA, De Serres G. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant? J Infect Dis. 2008;197(4):490-502. (Pubitemid 351321525)
13. Glezen WP, Gaglani MJ, Kozinetz CA, Piedra PA. Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza virus variants. J Infect Dis. 2010;202(11):1626-33.
14. Lewin EB. A paradigm for the control of influenza. J Infect Dis. 2010;202(11):1619-22.
15. Pearson ML, Bridges CB, Harper SA. Influenza vaccination of health-care personnel: recommendations of the Healthcare Infection Control Practices Advisory Committee (HICPAC) and the Advisory Committee on Immunization Practices (ACIP). MMWR. 2006;55(RR-2):1-16.
16. Kuehn BM. Mandatory influenza vaccination urged for clinicians, other health workers. JAMA. 2010;304(14):1545.
17. Chang Y-C, Chou Y-J, Liu J-Y, Yeh T-F, Huang N. Additive benefits of pneumococcal and influenza vaccines among elderly persons aged 75 years or older in Taiwan: a representative population-based comparative study. J Infect Dis. 2012;65(3):231-8.
18. McElhaney JE. The unmet need in the elderly: designing new influenza vaccines for older adults. Vaccine. 2005;23(suppl 1):S10-25.
19. Cox NJ, Subbarao K. Influenza. Lancet. 1999; 354(9186):1277-82. (Pubitemid 29469365)
20. Sangil A, Calbo E, Robles A, Benet S, Viladot ME, Pascual V, et al. Aetiology of community-acquired pneumonia among adults in an H1N1 pandemic year: the role of respiratory viruses. Euro J Clin Microbiol Infect Dis. 2012;31(10):2765-72.
21. Afilalo M, Stern E, Oughton M. Evaluation and management of seasonal influenza in the emergency department. Emerg Med Clin North Am. 2012;30(2):271-305.
22. United States Centers for Disease Control and Prevention. Seasonal influenza: who should get vaccinated against influenza. Available from: http://www.cdc.gov/flu/protect/who shouldvax.htm. Accessed 22 August 2012.
23. Whitley RJ, Monto AS. Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents. J Infect Dis. 2006;194(suppl 2):S133-8. (Pubitemid 44630957)
24. Wu U-I, Wang J-T, Ho Y-C, Pan S-C, Chen Y-C, Chang S-C. Factors associated with development of complications among adults with influenza: A 3-year prospective analysis. J Formos Med Assoc. 2012;111(7):364-9.
25. Monto AS, Ansaldi F, Aspinall R, McElhaney JE, Montaño LF, Nichol KL, et al. Influenza control in the 21st century: Optimizing protection of older adults. Vaccine. 2009;27(37):5043-53.
26. Molinari N-AM, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25(27):5086-96. (Pubitemid 46879994)
27. Chartrand C, Leeflang MMG, Minion J, Brewer T, Pai M. Accuracy of rapid influenza diagnostic tests: a meta-analysis. Ann Intern Med. 2012;156(7):500-11.
28. Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hayden FG, et al. Seasonal influenza in adults and children: diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(8):1003-32.
29. Mattison M, Marcantonio ER. Hospital management of older adults. UpToDate. Waltham, MA: UpToDate; 2012. Available from: http://www.uptodate.com/ contents/hospital-management-of-older-adults. Accessed on 14 June 2013.
30. Jefferson T, Jones MA, Doshi P, Del Mar CB, Heneghan CJ, Hama R, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2012;1(18):CD008965.
31. Hsu J, Santesso N, Mustafa R, Brozek J, Chen YL, Hopkins JP, et al. Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies. Ann Intern Med. 2012;156(7):512-24.
32. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR. 2010;59(RR-8):1-62.
33. Jefferson T, Foxlee R, Del Mar C, Dooley L, Ferroni E, Hewak B, et al. Interventions for the interruption or reduction of the spread of respiratory viruses. Cochrane Database Syst Rev. 2007;(4):CD006207.
34. Grayson ML, Melvani S, Druce J, Barr IG, Ballard SA, Johnson PDR, et al. Efficacy of soap and water and alcohol-based hand-rub preparations against live H1N1 influenza virus on the hands of human volunteers. Clin. Infect Dis. 2009;48(3):285-91.
35. Bonvehí PE, Istúriz RE, Labarca JA, Rüttimann RW, Vidal EI, Vilar-Compte D. Influenza among adults in Latin America, current status, and future directions: a consensus statement. Rev Panam Salud Publica. 2012;31(6):506-12.
36. Hannoun C, Megas F, Piercy J. Immunogenicity and protective efficacy of influenza vaccination. Virus Res. 2004;103(1-2):133-8. (Pubitemid 38649072)
37. Gross PA, Russo C, Dran S, Cataruozolo P, Munk G, Lancey SC. Time to earliest peak serum antibody response to influenza vaccine in the elderly. Clin Diagn Lab Immunol. 1997;4(4):491-2. (Pubitemid 27321787)
38. Cate TR, Couch RB, Parker D, Baxter B. Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines -1978. Clin Infect Dis. 1983;5(4):737-47.
39. Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet. 2005;366(9492):1165-74. (Pubitemid 41393594)
40. Gurfinkel EP, De la Fuente RL. Two-year follow-up of the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Registry. Tex Heart Inst J. 2004;31(1):28-32. (Pubitemid 38366812)
41. Stamboulian D, Bonvehí PE, Nacinovich FM, Rüttimann RW. Immunization against influenza in the elderly: the Argentinian experience, 1993-1997. Vaccine. 1999;17(suppl 1): S53-6. (Pubitemid 29366934)
42. Lambert LC, Fauci AS. Influenza vaccines for the future. N Engl J Med. 2010;363(21):2036-44.
43. Tsai TF. MF59 adjuvanted seasonal and pandemic influenza vaccines. Yakugaku Zasshi. 2011;131(12):1733-41.
44. Pellegrini M, Nicolay U, Lindert K, Groth N, Della Cioppa G. MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database. Vaccine. 2009;27(49):6959-65.
45. Schultze V, D'Agosto V, Wack A, Novicki D, Zorn J, Hennig R. Safety of MF59 adjuvant. Vaccine. 2008;26(26):3209-22.
46. Mannino S, Villa M, Apolone G, Weiss NS, Groth N, Aquino I, et al. Effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy. Am J Epidemiol. 2012;176(6):527-33.
47. Lambert PH, Laurent PE. Intradermal vaccine delivery: will new delivery systems transform vaccine administration? Vaccine. 2008;26(26): 3197-208.
48. Nicolas J-F, Guy B. Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice. Expert Rev Vaccines. 2008;7(8):1201-14.
49. Falsey AR, Treanor JJ, Tornieporth N, Capellan J, Gorse GJ. Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. J Infect Dis. 2009;200(2):172-80.
50. Bridges CB, Katz JM, Levandowski RA, Cox NJ. Inactivated influenza vaccines. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. 5th ed. Philadelphia, PA: Elsevier Inc; 2008. Pp. 259-290.